Skip to main content

Table 1 Patient characteristics

From: Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis

 

BP-naïve group

BP group

 
 

N

Median

Mean

95 %-CI of mean

N

Median

Mean

95 %-CI of mean

p-value

Age (years)

40

59.5

61.9

59.14-64.66

20

67.5

66.2

62.2-70.3

0.044

Height (cm)

39

163.0

164.0

161.7-166.3

20

160.5

160.7

157.3-164.1

0.159

Weight (kg)

38

70.0

71.61

67.2-76.0

20

69.5

68.6

63.3-74.2

0.584

Muscle area at 33 % of femur (mm2)

40

6392.4

6381.7

6055.5-6708.0

20

5291.2

5632.0

5094.2-6169.9

0.013

Age at menopause (yrs)

38

50.00

48.47

46.28-50.67

19

48.0

47.3

44.32-50.31

0.329

Time since menopause (yrs)

38

14.00

15.03

11.99-18.07

19

21.0

20.8

15.65-25.93

0.045

Duration of RA (yrs)

39

11.00

13.67

10.74-16.59

17

15.0

21.1

14.32-27.92

0.040